Delivery Order SPE2DB22D1202-SPE2DB24FVHK2

Award Date 7/18/24
Potential Completion Date 7/19/24
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,082.84 firm fixed-price contract is for the supply of REPATHA 140 MG/ML SURECLICK medications, with a period of performance through June 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a prescription medication, at a firm fixed price of $2,152.06. The contract has an ultimate completion date of May 15, 2025 and was awarded on May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $1,016.82 firm fixed price contract is for the supply of REPATHA 140 MG/ML SURECLICK medication. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a medication, with a ceiling value of $1,735.70 and a completion date of June 24, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a medication, and has a firm fixed price of $1,450.92 with a completion date of May 20, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the provision of REPATHA 140 MG/ML SURECLICKML, a specialty pharmaceutical product. The contract has a potential value of $1,801.86 and a completion date of February 23, 2024. This delivery order is issued under a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,400.11 firm-fixed-price contract is for the supply of REPATHA 140 MG/ML SURECLICK medication. The award has an ultimate completion date of May 20, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a specialty medication, with a ceiling value of $13,987.53 and a period of performance through November 13, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,623.68, is for the supply of REPATHA 140 MG/ML SURECLICK ML, a specialty medication. The contract is a firm fixed-price arrangement, with a period of performance through May 9, 2024. The contract was not set aside for any specific business category. Amerisourcebergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication, with a firm fixed price ceiling value of $1,467.09 and an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVHK2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $25,342.43, is for the supply of REPATHA 140 MG/ML SURECLICK ML, a prescription medication. The contract is a firm fixed-price award with a performance period through July 19, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA, valued up to $999,999,999 through December 2025, which encompasses the delivery of a comprehensive range of pharmaceutical and medical products to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/17/24, 9:25 AM